Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib in Severe Refractory Asthma (KIA)
NCT01097694Phase 2Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Nov 2010
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in asthma, sponsored by Brigham and Women's Hospital. Started Nov 2010; status: completed.
02
Drugs
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01097694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01097694.